NephroGenex, Inc. 4
4 · NephroGenex, Inc. · Filed May 4, 2015
Insider Transaction Report
Form 4
Hamill John
Chief Financial Officer
Transactions
- Award
Options to Purchase Common Stock
2015-04-30+15,000→ 15,000 totalExercise: $7.31From: 2016-04-30Exp: 2025-04-30→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the options will vest on April 30, 2016 and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following April 30, 2016.